rapid-acting antidepressants

Two Signaling Pathways Involved in Regulating Synaptic Plasticity Suggest Novel Targets for Rapid-Acting Antidepressants

Researchers have reported progress in the important effort to explain the rapid antidepressant action of ketamine, and in so doing,... Read More

Positive Phase 3 Test of Rapid-Acting Oral Medicine for Postpartum Depression

An investigational medicine called zuranolone has generated significant, rapid, and enduring symptom reduction in women with postpartum depression . The... Read More

Positive Results in Trial Testing ‘Laughing Gas’ in Severely Depressed Treatment-Resistant Patients

Newly reported results of a small phase 2 clinical trial indicate the potential utility of using nitrous oxide treatments in... Read More

Remarkable Results in a Preliminary Clinical Test of a Rapid-Acting Antidepressant Treatment

Imagine a new treatment for people with major depression who have not responded to existing treatments—one that acts rapidly and... Read More

In a Surprising Clinical Trial, Ketamine’s Antidepressant Effects Lasted Longer

Carefully designed, exquisitely controlled experiments sometimes don't produce the result predicted in advance—the research “hypothesis” that is the starting point... Read More